Live Breaking News & Updates on Casi Long

Stay updated with breaking news from Casi long. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Rating) in a report released on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. CASI Pharmaceuticals Price Performance CASI opened at $2.75 on Monday. CASI Pharmaceuticals has a fifty-two week low of $1.45 and a fifty-two […] ....

New Zealand General , New Zealand , Pharmaceuticals Daily , Wellington Shields Co , Citigroup Inc , Susquehanna International Group , Pharmaceuticals Inc , Virtu Financial , Wellington Shields Capital Management , Pharmaceuticals Price Performance , Get Rating , Shields Capital Management , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

HC Wainwright Weighs in on CASI Pharmaceuticals, Inc.'s Q2 2023 Earnings (NASDAQ:CASI)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Rating) – Research analysts at HC Wainwright lifted their Q2 2023 earnings estimates for shares of CASI Pharmaceuticals in a research report issued to clients and investors on Monday, May 22nd. HC Wainwright analyst S. Lee now expects that the biotechnology company will earn ($0.50) per share for the […] ....

Pharmaceuticals Inc , Virtu Financial , Prudential Financial Inc , Pharmaceuticals Daily , Casi Pharmaceuticals Inc , Susquehanna International Group , Pharmaceuticals Trading , Citigroup Inc , Renaissance Technologies , Get Rating , International Group , Casi Pharmaceuticals , Nasdaq Casi , Earnings Estimates , Hc Wainwright ,